Summary:
- Researchers have identified specific genetic markers and early treatment responses that predict which Graves' disease patients are likely to be resistant to standard antithyroid drug therapy.
- The study utilizes advanced genomic analysis and clinical data modeling to improve personalized medicine approaches for autoimmune thyroid conditions.